SCHEDULE 13G

Company

Oruka Therapeutics, Inc.

Filed

August 13, 2007

Accession Number

0001019056-07-000751

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →